Differential expression of CA125 and a novel serum tumor marker HE4 in epithelial ovarian cancer

被引：4
作者：
Brown, A.
Miller, C.
Robison, K.
Somers, E.
Allard, J.
Granai, C. O.
Skates, S.
Bast, R. C., Jr.
Moore, R. G.
机构：
[1] Hartford Hosp, Hartford, CT 06115 USA
[2] Fujirebio Diagnost Inc, Malvern, PA USA
[3] Brown Univ, Women & Infants Hosp, Providence, RI USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5533
引用
收藏
页数：1
相关论文
共 50 条
[41]   A COMPARISON OF HE4 WITH CA 125 AS TUMOR MARKERS IN PATIENTS WITH OVARIAN CANCER [J].
Nikolova, T. ;
Dimitrov, G. ;
Antovska, V. ;
Eftimovska, N. ;
Nikolova, N. ;
Janusevska, A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
[42]   Evaluation of CA125 and HE4 diagnostic performance in hereditary and sporadic ovarian cancer [J].
Tartaglione, S. ;
Manganaro, L. ;
Di Trani, M. ;
Viggiani, V. ;
Tomao, F. ;
Angeloni, A. ;
Anastasi, E. .
CLINICA CHIMICA ACTA, 2019, 493 :S158-S159
[43]   Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis [J].
Wang, Jiwen ;
Gao, Jia ;
Yao, Hongwen ;
Wu, Zongyong ;
Wang, Minjie ;
Qi, Jun .
TUMOR BIOLOGY, 2014, 35 (06) :6127-6138
[44]   Serum NLR combined with CA125 and HE4 improves the diagnostic and prognostic efficiency in patients with ovarian cancer [J].
Tian, Yun ;
Li, Xiabing ;
Zhang, Hongjian ;
Wang, Yaping ;
Li, Hongyu ;
Qin, Qiaohong .
FRONTIERS IN ONCOLOGY, 2024, 14
[45]   HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer [J].
Ortiz-Munoz, Blanca ;
Aznar-Oroval, Eduardo ;
Garcia Garcia, Ana ;
Covisa Peris, Amparo ;
Perez Ballestero, Pilar ;
Sanchez Yepes, Marina ;
Garcia Lozano, Tomas ;
Illueca Ballester, Carmen ;
Garcia Garcia, Enrique .
TUMOR BIOLOGY, 2014, 35 (07) :7249-7258
[46]   Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125 [J].
Shah, Chirag A. ;
Lowe, Kimberly A. ;
Paley, Pamela ;
Wallace, Erin ;
Anderson, Garnet L. ;
McIntosh, Martin W. ;
Andersen, M. Robyn ;
Scholler, Nathalie ;
Bergan, Lindsay A. ;
Thorpe, Jason D. ;
Urban, Nicole ;
Drescher, Charles W. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (05) :1365-1372
[47]   The Establishment of an HE4-CLIA Method and the Combined Analysis of HE4 and CA125 in Ovarian Cancer [J].
Zhang, Qiong ;
Wang, Cong-Rong ;
Yu, Juan-Ping ;
Ma, Qiang ;
Xu, Wei-Wen .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2016, 30 (05) :709-718
[48]   No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting [J].
Jacob, Francis ;
Meier, Mara ;
Caduff, Rosmarie ;
Goldstein, Darlene ;
Pochechueva, Tatiana ;
Hacker, Neville ;
Fink, Daniel ;
Heinzelmann-Schwarz, Viola .
GYNECOLOGIC ONCOLOGY, 2011, 121 (03) :487-491
[49]   Preoperative CA125 and HE4 in patients with endometrial cancer [J].
Antonsen, Sofie ;
Hogdall, Estrid ;
Andersen, Erik ;
Jochumsen, Kirsten ;
Lydolph, Magnus ;
Hogdall, Claus .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2012, 91 :63-63
[50]   Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women [J].
Gentry-Maharaj, Aleksandra ;
Blyuss, Oleg ;
Ryan, Andy ;
Burnell, Matthew ;
Karpinskyj, Chloe ;
Gunu, Richard ;
Kalsi, Jatinderpal K. ;
Dawnay, Anne ;
Marino, Ines P. ;
Manchanda, Ranjit ;
Lu, Karen ;
Yang, Wei-Lei ;
Timms, John F. ;
Parmar, Max ;
Skates, Steven J. ;
Bast, Robert C., Jr. ;
Jacobs, Ian J. ;
Zaikin, Alexey ;
Menon, Usha .
CANCERS, 2020, 12 (07) :1-12
12345